Inhibition of steroid sulfatase activity by danazol

Lab / animal OA: closed CC0 ⤵ 14 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Danazol at therapeutic concentrations potently inhibits human steroid sulfatase activity in liver and breast tumor preparations, impacting estrogen formation from estrone sulfate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The hydrolysis of dehydroepiandrosterone sulfate (DHAS) by human liver cells in culture and the hydrolysis of and formation of estradiol-17 beta (E2) from estrone sulfate (E1S) by human breast tumor preparations in vitro were studies in the presence and absence of danazol. In the latter tissue the effects of medroxyprogesterone acetate (MPA), trilostane, aminoglutethimide (AG) and tamoxifen were tested for comparison. Danazol at concentrations of 10(-6) - 1.4 X 10(-4) M strongly inhibited the hydrolysis of DHAS as well as the hydrolysis of and formation of E2 from E1S. With the exception of a slight inhibitory effect of trilostane upon E1S hydrolysis, the other four drugs did not inhibit the metabolism of E1S. Danazol, at concentrations corresponding to those occurring in vivo during therapy, is a potent inhibitor of steroid sulfatase activity. This may be one of the ways in which the drug affects peripheral and target tissue levels of steroid hormones.

My notes (saved in your browser only)

MeSH descriptors

Danazol Pregnadienes Aminoglutethimide Aminoglutethimide Breast Neoplasms Breast Neoplasms Carcinoma Carcinoma Culture Techniques Danazol Dehydroepiandrosterone Dehydroepiandrosterone Dehydroepiandrosterone Dehydroepiandrosterone Dehydroepiandrosterone Sulfate Dihydrotestosterone Dihydrotestosterone Dihydrotestosterone Estrogen Antagonists Estrogen Antagonists

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (14)

Source provenance

openalex
last seen: 2026-05-11T03:33:30.611205+00:00
pubmed
last seen: 2026-10-08T21:58:08.863946+00:00
unpaywall
last seen: 2026-10-19T06:34:38.229974+00:00
License: CC0 · commercial use OK